A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
Clinical trial NCT03766685 · COMPLETED
Trial details
- NCT number
- NCT03766685
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2020-07-14
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.